Cabergoline

Endocrinology

Endocrinology · Dopamine D2 agonist

Cabergoline

Dose

0.25 mg twice weekly; titrate monthly to prolactin response (usual 0.5–1 mg twice weekly).

Use

Prolactinoma and hyperprolactinaemia.

Monitoring

Prolactin, visual fields if macroadenoma, echocardiogram if high cumulative dose.

Side effects

  • Nausea
  • Postural hypotension
  • Impulse-control disorder
  • Cardiac valvulopathy (high dose)

Related in WardRound

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds